Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07552168
What this trial is testing

INSPIRE: INnovative SABR for Prostate Cancer All IREland

Who this might be right for
Prostate Adenocarcinoma
Cancer Trials Ireland 136
Not applicableStudy completedNCT03159676
What this trial is testing

Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 150
Not applicableWithdrawnNCT00621413
What this trial is testing

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
IsoRay Medical, Inc.
Not applicableLooking for participantsNCT03836196
What this trial is testing

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 105
Large-scale testing (Phase 3)UnknownNCT00175396
What this trial is testing

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Who this might be right for
Prostate Cancer
University of British Columbia 400
Not applicableStudy completedNCT00899912
What this trial is testing

Changes in DNA After Radiation Therapy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 13
Large-scale testing (Phase 3)Study completedNCT00664456
What this trial is testing

Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 421
Large-scale testing (Phase 3)Looking for participantsNCT05019846
What this trial is testing

SRT Versus SRT+ADT in Prostate Cancer

Who this might be right for
Prostate Cancer
Marco Lorenzo Bonu 310
Testing effectiveness (Phase 2)Study completedNCT02874014
What this trial is testing

Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 56
Testing effectiveness (Phase 2)WithdrawnNCT00598858
What this trial is testing

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+1 more
John P. Fruehauf
Not applicableActive Not RecruitingNCT03383016
What this trial is testing

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

Who this might be right for
EpidemiologyProstate Cancer
CHU de Quebec-Universite Laval 2,053
Not applicableActive Not RecruitingNCT06451614
What this trial is testing

SpaceIT Hydrogel System for Perirectal Spacing

Who this might be right for
Prostate Cancer
Boston Scientific Corporation 230
Testing effectiveness (Phase 2)UnknownNCT01909388
What this trial is testing

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Alfonso Gomez-Iturriaga 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04025372
What this trial is testing

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Who this might be right for
Prostate Cancer
Brigham and Women's Hospital 234
Not applicableUnknownNCT03979573
What this trial is testing

Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer

Who this might be right for
Prostate Cancer
Heinrich-Heine University, Duesseldorf 90
Not applicableUnknownNCT02790216
What this trial is testing

Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Sheba Medical Center 24
Not applicableWithdrawnNCT02546427
What this trial is testing

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Who this might be right for
Prostate Cancer
Albert J. Chang
Not applicableStudy completedNCT02125175
What this trial is testing

BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
The Clatterbridge Cancer Centre NHS Foundation Trust 55
Not applicableStudy completedNCT01605097
What this trial is testing

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 26
Not applicableStudy completedNCT04582656
What this trial is testing

Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Koelis 76
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation